Rapid measurement of intravoxel incoherent motion (IVIM) derived perfusion fraction for clinical magnetic resonance imaging

Table 3 Previous IVIM studies of different pathologies and the reported IVIM parameters

Study	Pathology	No. of patients	D*/D	D*	f
Bisdas et al. [38]	Low-grade glioma	7	20.8	10.8	0.06
Bisdas et al. [38]	High-grade glioma	15	54.7	41.6	0.11
Federau et al. [4]	Low-grade glioma	5	11.4	11.4	0.08
Federau et al. [4]	High-grade glioma	16	5.85	11.7	0.13
Hu et al. [17]	Low-grade glioma	13	2.84	2.15	0.48
Hu et al. [17]	High-grade glioma	29	5.35	2.71	0.29
Lin et al. [39]	Low-grade glioma	13	24.7	2.77	0.49
Lin et al. [39]	High-grade glioma	11	29.0	5.10	0.40
Suo et al. [6]	Ischemic stroke	101	24.3	10.2	0.04
Cho et al. [3]	Breast cancer	14	10.7	15.0	0.13
Sigmund et al. [30]	Breast cancer	27	6.40	15.1	0.10
Hayashi et al. [32]	Cirrhotic liver	29	28.7	25.0	0.24
Luciani et al. [8]	Cirrhotic liver	12	51.2	61.0	0.30
Patel et al. [9]	Cirrhotic liver	14	26.8	27.9	0.25
Kuru et al. [34]	Prostate cancer	27	29.9	31.1	0.10
Ueda et al. [35]	Prostate cancer	63	11.5	7.48	0.23
Hectors et al. [5]	Hepatocellular carcinoma	25	47.1	64.1	0.18
Woo et al. [33]	Low-grade hepatocellular carcinoma	24	31.1	36.6	0.22
Woo et al. [33]	High-grade hepatocellular carcinoma	18	32.5	32.3	0.19
Lemke et al. [12]	Pancreatic adenocarcinoma	23	17.4^a	20.0^a	0.09
Kang et al. [36]	Chronic pancreatitis	7	28.9	40.8	0.19
	Neuroendocrine tumour	17	39.4	43.7	0.30
	Pancreatic adenocarcinoma	39	19.6	22.3	0.12
	Intraductal papillary mucinous neoplasm	37	5.49	15.6	0.10
Klauss et al. [37]	Chronic pancreatitis	9	18.7^a	20.0^a	0.16
Klauss et al. [37]	Pancreatic adenocarcinoma	15	18.7^a	20.0^a	0.08